— Know what they know.
Not Investment Advice
Also trades as: CLLS (NASDAQ) · $vol 0M · CMVLF (OTC) · $vol 0M

ALCLS.PA PAR

Cellectis S.A.
1W: +0.0% 1M: -57.6% 3M: -54.2% YTD: -63.0% 1Y: -45.4% 3Y: -29.0% 5Y: -89.4%
€1.25 ($1.41)
-0.04 (-2.79%)
 
Weekly Expected Move ±24.6%
€1 €1 €1 €2 €2
PAR · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · €90.7M mcap · 54M float · 0.547% daily turnover

Cash Flow Trends

Operating Cash Flow
-$42M -281.1% ▼
Capital Expenditures
$2M +36.1% ▲
5Y CAGR: -44.4%
Free Cash Flow
-$44M -330.3% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$99M -1611.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$125M-$99M-$117M-$37M-$70M
Depreciation & Amort.$17M$18M$19M$20M$21M
Stock-Based Comp.$11M$6M$5M$3M$0
Change in Working Capital-$4M-$6M$49M$54M-$43M
Other Non-Cash Items-$6M-$8M$19M-$16M$51M
Operating Cash Flow-$105M-$87M-$25M$23M-$42M
— Investing Activities —
Capital Expenditures-$20M-$2M-$1M-$3M-$4M
Acquisitions (Net)-$15M$0$0$0$0
Investment Purchases-$143K$0$0-$163M-$166M
Investment Sales$15M$126K$0$64M$139M
Other Investing$27M-$446K-$14M-$1M$0
Investing Cash Flow$7M-$3M-$16M-$103M-$31M
— Financing Activities —
Net Debt Issuance-$11M-$7M$13M$7M-$6M
Stock Repurchased$0-$569K$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$14M$8M$1M-$847K-$11M
Financing Cash Flow$48M$1M$83M$89M-$17M
Net Change in Cash-$56M-$92M$43M$7M-$99M
Cash End of Period$186M$93M$137M$143M$64M
Free Cash Flow-$124M-$90M-$26M$19M-$44M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms